0.5177
                                            전일 마감가:
              $0.543
            열려 있는:
              $0.5473
            하루 거래량:
                3.72M
            Relative Volume:
              0.18
            시가총액:
                $51.39M
            수익:
              -
            순이익/손실:
              $-12.89M
            주가수익비율:
              -0.2046
            EPS:
                -2.53
            순현금흐름:
                $-11.95M
            1주 성능:
              -14.05%
            1개월 성능:
              -29.20%
            6개월 성능:
                -20.10%
            1년 성능:
              -61.65%
            Plus Therapeutics Inc Stock (PSTV) Company Profile
명칭
                  
                      Plus Therapeutics Inc
                    
                전화
                  
                      737.255.7194
                    
                주소
                  
                      4200 MARATHON BLVD., AUSTIN, TX
                    
                PSTV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                PSTV
                            
                             
                        Plus Therapeutics Inc 
                           | 
                    0.5177 | 53.90M | 0 | -12.89M | -11.95M | -2.53 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 | 
|---|---|---|---|
| 2025-09-03 | 업그레이드 | D. Boral Capital | Hold → Buy | 
| 2025-03-17 | 개시 | D. Boral Capital | Buy | 
| 2021-01-25 | 개시 | Ladenburg Thalmann | Buy | 
| 2020-10-16 | 개시 | Maxim Group | Buy | 
Plus Therapeutics Inc 주식(PSTV)의 최신 뉴스
Is Plus Therapeutics Inc. forming a reversal patternJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
How interest rate cuts could boost Plus Therapeutics Inc. stock2025 Price Momentum & Consistent Growth Stock Picks - newser.com
Is Plus Therapeutics Inc. forming a bottoming baseEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Will Plus Therapeutics Inc. stock gain from strong economyPortfolio Return Summary & Long-Term Capital Growth Ideas - newser.com
Will Plus Therapeutics Inc. outperform the marketBreakout Watch & Verified Technical Trade Signals - newser.com
Plus Therapeutics stock price target lowered to $2 at H.C. Wainwright - Investing.com UK
Smart tools for monitoring Plus Therapeutics Inc.’s price action2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Plus Therapeutics (PSTV) Analyst Rating Update: Price Target Low - GuruFocus
HC Wainwright & Co. Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
How dovish Fed policy supports Plus Therapeutics Inc. (XMP0) stock2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
Order flow analysis tools used on Plus Therapeutics Inc.Insider Buying & Step-by-Step Swing Trade Plans - newser.com
Can Plus Therapeutics Inc. rally from current levelsJuly 2025 Levels & Daily Oversold Bounce Ideas - newser.com
Applying Wyckoff theory to Plus Therapeutics Inc. stock2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Will Plus Therapeutics Inc. benefit from macro trendsGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
How Plus Therapeutics Inc. (XMP0) stock compares with tech leadersTrade Entry Report & Smart Money Movement Tracker - newser.com
What MACD signals say about Plus Therapeutics Inc.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com
What momentum shifts mean for Plus Therapeutics Inc.Market Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Can a trend reversal in Plus Therapeutics Inc. lead to recoveryMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Candlestick signals on Plus Therapeutics Inc. stock todayQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Should you hold or exit Plus Therapeutics Inc. nowTrend Reversal & Daily Momentum Trading Reports - newser.com
Why Plus Therapeutics Inc. stock remains on watchlistsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Applying Elliott Wave Theory to Plus Therapeutics Inc.Market Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Is Plus Therapeutics Inc. stock positioned for long term growthMarket Risk Report & Real-Time Market Trend Scan - newser.com
Is Plus Therapeutics Inc. (XMP0) stock attractive for growth funds2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Can Plus Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Plus Therapeutics, Inc. (NASDAQ:PSTV) Given Average Rating of "Buy" by Brokerages - MarketBeat
How to use Fibonacci retracement on Plus Therapeutics Inc.July 2025 Action & High Accuracy Trade Signal Alerts - newser.com
Is Plus Therapeutics Inc. stock positioned for digital transformation2025 Year in Review & Daily Momentum Trading Reports - newser.com
D. Boral Capital Reiterates Buy Rating for Plus Therapeutics (NASDAQ:PSTV) - MarketBeat
Is Plus Therapeutics Inc. stock dividend yield sustainableQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
MSN Money - MSN
Plus Therapeutics’ ARISE Study: A New Hope for Fertility Treatment - MSN
Is Plus Therapeutics Inc. (XMP0) stock protected from inflationJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Plus Therapeutics (NASDAQ:PSTV) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
PSTV: Analyst Maintains 'Buy' Rating and $5 Price Target Today | - GuruFocus
Plus Therapeutics Eyes Expansion Despite Wider Quarterly Loss - Finimize
D. Boral Capital Maintains Plus Therapeutics (PSTV) Buy Recommendation - Nasdaq
What MACD and RSI say about Plus Therapeutics Inc.Quarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Plus: Q3 Earnings Snapshot - Stamford Advocate
Why Plus Therapeutics Inc. stock could outperform in 20252025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Multi factor analysis applied to Plus Therapeutics Inc.July 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
Plus Therapeutics Inc (PSTV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
                자본화:
                 
                  | 
                볼륨(24시간):